1 Min Read
Aug 10 (Reuters) - APTAHEM AB
* BIOSPRING HAS BEEN CONTRACTED FOR SUBSTANCE PRODUCTION OF DRUG CANDIDATE APTA-1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.